Therapy Optimisation Using High-frequency and High-dosage Administration of Interferon-beta (Rebif) in MS Patients. Case Series for Adjustment of Treatment Strategy and Its Monitoring.

Trial Profile

Therapy Optimisation Using High-frequency and High-dosage Administration of Interferon-beta (Rebif) in MS Patients. Case Series for Adjustment of Treatment Strategy and Its Monitoring.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Aug 2012

At a glance

  • Drugs Interferon beta-1a (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Merck KGaA
  • Most Recent Events

    • 14 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top